Table 1.
Purpose | Results | References | |
---|---|---|---|
In vitro | DEX effect on HeLa cells under hypoxic conditions | Induction of hypoxia-dependent gene expression | (61) |
Increased HRE-luciferase activity | |||
The LBD of GR is necessary for HRE-luciferase activity | |||
Exposure of HK-2 cells or AtT-20 cells to hypoxia | Upregulation of GR mRNA and protein levels due to binding of HIF1α to HREs present in the NR3C1 promotor | (62, 63) | |
The effect of GCs on HIF1α function (HepG2 cells) | Attenuation of HIF1α activity upon hypoxia and DEX stimulation as a results of reduced DNA binding and HRE activity associated with problems with HIF1α nuclear translocation | (64) | |
Characterization of the hypoxic effect on GR levels and its anti-inflammatory actions in A549 cells | Hypoxia causes a time-dependent downregulation of GR mRNA and protein levels and inhibits GR nuclear translocation | (66, 67, 69) | |
The anti-inflammatory effect of DEX is attenuated when A549 cells are exposed to hypoxia and stimulated with LPS or IL-1β | |||
Effect of chemical hypoxia (CoCl2) and/or DEX on RAW264.7 cells | GILZ is upregulated by hypoxia and is further increased upon DEX stimulation to prevent overactivation of immune cells (macrophages) and overproduction of pro-inflammatory cytokines (inhibition of IL-1β and IL-6 production) | (76) | |
In vivo | How is hypoxia affecting the endogenous GC pathway and vice versa in zebrafish larvae? | GCs stabilize HIF via pVHL degradation HIF represses GR activity and the GR response to exogenous GCs (e.g. BME) in vhl-/- zebrafish larvae |
(81, 82) |
Cortisol levels are reduced by HIF due to repression of POMC expression and intracellular blocking the transcriptional activity of GR | |||
GCs in AMS | Prophylactic effect of GCs when ascending to high altitude | Administration of GCs (DEX and prednisolone) prior to ascending to high altitude reduces the symptoms of AMS (suppresses inflammatory pathways, reduces vascular permeability and vasoconstriction, improves arterial oxygenation and induces a better antioxidant-oxidant balance) | (83–88) |
Perinatal hypoxia and GCs | Effect of GCs during perinatal hypoxia | Neonatal hypoxia leads to the activation of the HPA axis in the neonates and causes higher GC levels | (89, 90) |
GCs can have neuroprotective effects on neonatal HI-induced brain damage | (91–93) | ||
Ideal timing, dose and duration of GCs is necessary to prevent neurotoxic effects | (94, 95) |